Logo

American Heart Association

  2
  0


Final ID: MDP1086

A Body Shape Index at Age 25-64 Predicts Mortality and CHD Hospitalization

Abstract Body (Do not enter title and authors here): Introduction: Obesity is a known risk factor for cardiovascular disease (CVD) morbidity and mortality. A body shape index (ABSI) is a waist circumference (WC) measure of abdominal obesity independent of body mass index (BMI) that has been shown to predict mortality and numerous clinical outcomes.
Aims: To study the predictive value of ABSI in conjunction with BMI for all-cause mortality and coronary heart disease (CHD) hospitalization among adult participants.
Methods: Participants (n=2,225) were drawn from the First Israeli National Health and Nutrition Survey (1999-2001), constituting adults aged 25-64. Baseline anthropometrics, including weight, height, and WC, were measured and expressed as their allometric indices: BMI (weight/height2) and ABSI [WC/(BMI2/3*height1/2)]. Follow-up lasted through 2021 for mortality and 2022 for hospitalizations. Cox regressions assessed the adjusted risk of all-cause mortality and CHD hospitalization.
Results: The baseline mean [SD] age was 43 [11] years, and 50% were women. The correlation between BMI and WC was 0.78, and 0.02 for BMI and ABSI. Over a median follow-up of 21 years, 247 (11.1%) deaths occurred. The multivariable-adjusted hazard ratios (HRs) for mortality per 1 SD increase in BMI and ABSI were 1.11 (95% CI: 0.97; 1.27) and 1.55 (95% CI: 1.33; 1.79), respectively (Table). ABSI exhibited a significant association with mortality risk across all standard BMI categories; adjusted for demographics and classic CVD risk factors, the HRs (95% CIs) per 1 SD increase in ABSI were 1.38 (1.01; 1.88) for individuals with a BMI of 18.5-24.9, 1.70 (1.34; 2.16) for BMI 25.0-29.9, and 1.46 (1.13; 1.87) for BMI ≥30.0. Among CVD-free participants at baseline (n=2,146), 267 (12.4%) were hospitalized for CHD during follow-up. The latter had higher ABSI (0.082 vs. 0.078, P<.001) and BMI (28.1 vs. 26.7, P<.001) than individuals who remained free of CHD. An increase in the adjusted HR was seen for both ABSI [1.34 (95% CI: 1.15; 1.55)] and BMI [1.16 (95% CI: 1.01; 1.33)] (Table).
Conclusion: In a 20-year prospective study of a middle-aged cohort, baseline ABSI was a stronger predictor of mortality than BMI and predicted CHD hospitalization independently of BMI.
  • Shafran, Itamar  ( Tel Aviv University , Tel Aviv , Israel )
  • Krakauer, Nir  ( The City College of New York , New York City , New York , United States )
  • Krakauer, Jesse  ( Associated Physicians/Endocrinology , Berkley , Michigan , United States )
  • Cohen, Gali  ( Tel Aviv University , Tel Aviv , Israel )
  • Gerber, Yariv  ( Tel Aviv University , Tel Aviv , Israel )
  • Author Disclosures:
    Itamar Shafran: DO NOT have relevant financial relationships | Nir Krakauer: DO NOT have relevant financial relationships | Jesse Krakauer: DO NOT have relevant financial relationships | Gali Cohen: DO NOT have relevant financial relationships | Yariv Gerber: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Preventive Strategies for Cardiovascular Disease from Childhood to Adulthood

Sunday, 11/17/2024 , 09:30AM - 10:55AM

Moderated Digital Poster Session

More abstracts on this topic:
A novel reproducible low-cost model of acute myocardial infarction in swine

Li Yichen, Zheng Zilong, Tang Weijie, Chen Wangping, Yang Jinfu, Fan Chengming

Absence of standard modifiable risk factors (SMuRF-less) among 5002 Middle Eastern patients with atherosclerotic cardiovascular disease: (Interim analysis from the Jo-SMuRF Study)

Aldalal'ah Mo'men, Hammoudeh Ayman, Hamza Ibrahem, Alqudah Mohammad, Khasawneh Hasan, Alomari Sawsan, Alomari Ahmad, H. Assaf Sarah, Zaqqa Ayah, Khatatbeh Moawiah

You have to be authorized to contact abstract author. Please, Login
Not Available